Retina/RPE/choroid tissue was dissected from eyes in 10- × 10-mm segments, embedded in 5% agarose in 0.1 M phosphate-buffered saline (PBS), and sectioned at 100 μm using a vibratome (Technical Products International, Polysciences, Warrington, PA). Tissue sections were rinsed in PBS, blocked at 4°C for 6 hours in PBTA (PBS with 0.5% bovine serum albumin [Sigma, St. Louis, MO], 0.1% Triton X-100 [Roche, Indianapolis, IN], and 0.05% sodium azide [Sigma]) containing 5% normal donkey serum (Jackson ImmunoResearch Laboratories, West Grove, PA). Sections were then incubated overnight at 4°C in primary antibodies
(Table 1) , diluted in PBTA, rinsed, and incubated overnight at 4°C in donkey anti–mouse, anti–rabbit, or anti–goat IgG secondary antibodies conjugated to Cy2, Cy3, or Cy5 fluorochromes (Jackson ImmunoResearch Laboratories). Sections were then rinsed in PBS, mounted in 5%
n-propyl gallate in glycerol, and examined on a laser scanning confocal microscope (Olympus Fluoview 500; Olympus America, Melville, NY). Optimal iris and gain functions were determined for each primary antibody and maintained constant during the examination of all sections labeled with that probe. Images were acquired using Olympus software; pseudo double-labeled images were generated by optimizing the Cy3 (red) channel to allow visualization of autofluorescence from lipofuscin pigment in RPE cells and Bruch’s membrane. Drusen were identified using antibodies to apolipoprotein E
34 (ApoE). For each antibody, data were collected over a minimum of 10 drusen in each eye. Documented immunolabeling patterns were consistent in all eyes, those that were normal and those with AMD.